Shock in acute myocardial infarction: the Cape Horn for trials?
Open Access
- 7 July 2010
- journal article
- review article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 31 (15) , 1828-1835
- https://doi.org/10.1093/eurheartj/ehq220
Abstract
Despite therapeutic improvements, cardiogenic shock (CS) remains the most common cause of death in patients with acute myocardial infarction (AMI). In addition to percutaneous coronary intervention, inotropes, fluids, adjunctive medication, intra-aortic balloon counterpulsation, and also assist devices are widely used for treatment. However, currently, there is only limited evidence for any of the above treatments. This review will therefore outline the underlying causes, pathophysiology, and treatment of CS complicating AMI with major focus on interventional techniques and advancement of new therapeutical arsenals, both pharmacological and mechanical.Keywords
This publication has 46 references indexed in Scilit:
- Comparison of Dopamine and Norepinephrine in the Treatment of ShockNew England Journal of Medicine, 2010
- Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trialsEuropean Heart Journal, 2009
- Thirty-Year Trends (1975 to 2005) in the Magnitude of, Management of, and Hospital Death Rates Associated With Cardiogenic Shock in Patients With Acute Myocardial InfarctionCirculation, 2009
- Management of acute myocardial infarction in patients presenting with persistent ST-segment elevationEuropean Heart Journal, 2008
- Early Revascularization and Long-term Survival in Cardiogenic Shock Complicating Acute Myocardial InfarctionJAMA, 2006
- Heart Disease and Stroke Statistics—2006 UpdateCirculation, 2006
- Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevationJournal of the American College of Cardiology, 2000
- Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial RegistryJournal of the American College of Cardiology, 2000
- A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock—(S)MASHEuropean Heart Journal, 1999
- Cardiogenic shock complicating acute myocardial infarction: Predictors of deathAmerican Heart Journal, 1999